Mental Ability Tests

BEHAVIORAL3 trials

Sponsors

M.D. Anderson Cancer Center

Conditions

Advanced Cancers

Phase 2

Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea

CompletedNCT01832402

M.D. Anderson Cancer CenterAdvanced Cancers

Start: 2013-06-11End: 2019-11-25Updated: 2023-06-08

Sublingual Fentanyl for the Management of Breakthrough Pain

TerminatedNCT02514252

M.D. Anderson Cancer CenterAdvanced Cancers

Start: 2016-02-02End: 2019-11-04Updated: 2021-05-18

Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea

CompletedNCT02597478

M.D. Anderson Cancer CenterAdvanced Cancers

Start: 2016-01-04End: 2021-01-27Updated: 2021-02-09

Related Papers

Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial.

2016-07-0934 citations